Cargando…
MiR‐664‐3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix
Osteoporosis is a metabolic disorder characterized by low bone mass and deteriorated microarchitecture, with an increased risk of fracture. Some miRNAs have been confirmed as potential modulators of osteoblast differentiation to maintain bone mass. Our miRNA sequencing results showed that miR‐664‐3p...
Autores principales: | Xu, Yuexin, Jin, Yucui, Hong, Fangling, Ma, Yunfei, Yang, Jiashu, Tang, Yuting, Zhu, Zhu, Wu, Jiahui, Bao, Qianyi, Li, Lingyun, Yao, Bing, Li, Dong, Ma, Changyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178280/ https://www.ncbi.nlm.nih.gov/pubmed/33942497 http://dx.doi.org/10.1111/jcmm.16451 |
Ejemplares similares
-
Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression
por: Qu, Shuang, et al.
Publicado: (2018) -
miR-27a-3p negatively regulates osteogenic differentiation of MC3T3-E1 preosteoblasts by targeting osterix
por: Xu, Yuexin, et al.
Publicado: (2020) -
Osterix acetylation at K307 and K312 enhances its transcriptional activity and is required for osteoblast differentiation
por: Lu, Jianlei, et al.
Publicado: (2016) -
Characterization of Osterix Protein Stability and Physiological Role in Osteoblast Differentiation
por: Peng, Yanyan, et al.
Publicado: (2013) -
Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2019)